Browse the full directors' dealings record of CareCloud, Inc., a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, CareCloud, Inc. has logged 36 insider filings. The latest transaction was filed on 11 February 2022 — Levée d'options. Among the most active insiders: DALY JOHN N. Every trade is accessible without an account.
FY ended December 2025 · cache
25 of 36 declarations
CareCloud, Inc. is a U.S.-based healthcare technology company listed on the NASDAQ in the United States under the ticker CCLDO. The company offers a proprietary cloud-based platform and related services for medical practices, physician groups, and healthcare organizations, with the stated goal of improving revenue performance, administrative efficiency, and patient care delivery. Its core portfolio spans revenue cycle management (RCM), practice management (PM), electronic health records (EHR), analytics, patient experience management, telehealth, and complementary back-office services. The company positions these solutions as tools to reduce administrative burden, streamline workflows, and support better business and clinical decisions for providers. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1582982/000149315226009872/form10-k.htm?utm_source=openai)) CareCloud was founded in 1999 in New Jersey and is headquartered in Somerset, New Jersey, United States. Over time, the business has evolved from a focus on ambulatory healthcare solutions into a broader healthcare IT platform that serves a wide range of medical specialties and practice sizes. Its model combines software-as-a-service with managed services, which gives it exposure to recurring software revenues as well as service-led customer relationships. Management emphasizes an integrated suite designed for medical groups that want a single vendor approach across clinical, financial, and operational workflows. ([carecloud.com](https://carecloud.com/continuum/top-revenue-cycle-management-companies/?utm_source=openai)) From a competitive standpoint, CareCloud operates in a crowded but attractive healthcare IT market, competing with other RCM, EHR, and practice-management vendors. Its key differentiator is the breadth of its integrated offering: cloud software, revenue optimization tools, analytics, and services delivered under one umbrella. The company serves customers throughout the United States, so its geographic footprint is national rather than regionally concentrated. CareCloud also highlights coverage across many specialties, which can be important in selling to multi-site groups and specialty practices that require workflow customization and outsourced administrative support. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1582982/000149315226009872/form10-k.htm?utm_source=openai)) Recent developments suggest an active strategic reset. In 2026, CareCloud reported quarterly results, reiterated its growth outlook, announced a $50 million credit facility, and disclosed steps toward capital structure simplification. It also introduced AI-enabled products and communicated about a broader acquisition-led growth strategy, including the Medsphere assets transaction completed through a newly formed subsidiary in 2025. For investors, this makes CareCloud a U.S. NASDAQ-listed healthcare technology name with a mix of software, services, and M&A-driven expansion, while execution, leverage management, and product adoption remain central monitoring points. ([carecloud.com](https://carecloud.com/press-releases/?utm_source=openai))